Bumper Offer - Urjas oil Just @ Rs. 1
Emzosin D is an allopathic medicine The correct dosage of Emzosin D depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Emzosin D is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Emzosin D is used -
Severe
Moderate
Mild
Is the use of Emzosin D safe for pregnant women?
Pregnant women may get severe side effects after taking Emzosin D. If you are pregnant, do not take Emzosin D without a doctor's advice.
Is the use of Emzosin D safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Emzosin D. It should only be taken after medical advice.
What is the effect of Emzosin D on the Kidneys?
Emzosin D is completely safe for kidneys.
What is the effect of Emzosin D on the Liver?
The liver can be affected by Emzosin D. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Emzosin D only after medical advice.
What is the effect of Emzosin D on the Heart?
Using Emzosin D does not have any harmful effects on the heart.
Emzosin D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emzosin D unless your doctor advises you to do so -
Is this Emzosin D habit forming or addictive?
Forming a habit of Emzosin D has not been reported.
Interaction between Food and Emzosin D
Information is not available on the interaction of any foods with Emzosin D, due to a lack of research on this.
Interaction between Alcohol and Emzosin D
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Emzosin D.
Yes, Emzosin D might cause constipation. It is a rare side effect of this drug. However, the exact cause behind constipation is unknown. If you are experiencing constipation after taking this drug then try to take laxative such as Isabgol and eat less spicy highly fibrous food.
Take Emzosin D as directed by your doctor. Do not take this medicine longer than prescribed by your doctor to avoid unpleasant side effects.
No, Emzosin D and metoprolol should not be taken together because metoprolol is an antihypertensive drug which lowers the blood pressure and Emzosin D might also lower the blood pressure. Hence, you are advised to avoid taking Emzosin D and metoprolol together.
No, Emzosin D does not cause incontinence. In fact Emzosin D provides relief from urinary incontinence due to benign prostatic hyperplasia.
Take Emzosin D 1-2 times in a day or as advised by your doctor. It has to be taken with food because of the presence of food assists in the better absorption of this drug from the stomach. Precautions must be taken in patients with heart diseases, improper liver or kidney function.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uroxatral® (alfuzosin HCL)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 123-124
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uroxatral® (alfuzosin HCL)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 123-124
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)
